Apply to the MRC Impact Acceleration Award to address a single, high-risk development step and generate key data to de-risk a new medicine, medical device, diagnostic or other medical product.
You must be based at a research organisation eligible for MRC funding.
Apply for funding to establish a UK Obesity Research Institute, undertaking world-leading research into the mechanistic biomedical drivers of obesity and develop targeted interventions to prevent and treat obesity and its health consequences.
Applications must be led by a UK-based research organisation eligible for MRC funding.
Apply for funding for academically led experimental medicine studies in humans that deepen mechanistic understanding of the causal mechanisms underlying the effects of gambling activities, products and interventions in gambling disorder.
Under the UKRI-FAPESP lead agency agreement, participant UK Research and Innovation (UKRI) research councils receive and assess joint applications from eligible UK and Brazil-based researchers from the state of São Paulo on behalf of both organisations.
UKRI and FNR have signed a memorandum of understanding to enable and support applications between researchers in the UK and Luxembourg. UKRI will fund the UK component and FNR will fund the Luxembourg component of the application.
Conditions will differ depending on the funding opportunity.
Apply to collaborate with the functional genomics screening laboratory on projects using complex human in vitro models for CRISPR screening to better understand model biology.
You must be a researcher eligible for MRC funding.
Applications from UK based industry parties may also be considered.